https://business-news.org/article/419801-meunerie-sawyerville-inc-denial-of-hearing-final-debarment-order2026-10-17T06:34:12.890Z0.6https://business-news.org/article/419802-susceptibility-test-interpretive-criteria-recognized-and-listed-on-the-susceptibility-test2026-10-17T06:34:12.910Z0.6https://business-news.org/article/419803-e6-r2-good-clinical-practice-integrated-addendum-to-e6-r1-international-council-for-harmon2026-10-17T06:34:13.207Z0.6https://business-news.org/article/419804-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T06:34:13.535Z0.6https://business-news.org/article/419805-tissue-agnostic-therapies-in-oncology-regulatory-considerations-for-orphan-drug-designatio2026-10-17T06:34:22.354Z0.6https://business-news.org/article/419806-wyeth-pharmaceuticals-inc-et-al-withdrawal-of-approval-of-121-new-drug-applications-and-162026-10-17T06:34:21.997Z0.6https://business-news.org/article/419807-medical-devices-hematology-and-pathology-devices-classification-of-lynch-syndrome-test-sys2026-10-17T06:34:23.610Z0.6https://business-news.org/article/419808-q11-development-and-manufacture-of-drug-substances-questions-and-answers-chemical-entities2026-10-17T06:34:24.513Z0.6https://business-news.org/article/419809-psychopharmacologic-drugs-advisory-committee-notice-of-meeting-establishment-of-a-public-d2026-10-17T06:34:24.903Z0.6https://business-news.org/article/419810-center-for-drug-evaluation-and-research-and-you-keys-to-effective-engagement-public-worksh2026-10-17T06:34:24.663Z0.6https://business-news.org/article/419811-promoting-the-use-of-complex-innovative-designs-in-clinical-trials-public-meeting-request-2026-10-17T06:34:23.990Z0.6https://business-news.org/article/419812-determination-of-regulatory-review-period-for-purposes-of-patent-extension-zydelig-new-dru2026-10-17T06:34:31.135Z0.6https://business-news.org/article/419813-sebela-ireland-ltd-et-al-withdrawal-of-approval-of-24-abbreviated-new-drug-applications2026-10-17T06:34:31.133Z0.6https://business-news.org/article/419814-joint-meeting-of-the-blood-products-advisory-committee-and-the-microbiology-devices-panel-2026-10-17T06:34:35.693Z0.6https://business-news.org/article/419815-agency-information-collection-activities-proposed-collection-comment-request-guidance-for-2026-10-17T06:34:34.854Z0.6https://business-news.org/article/419816-determination-of-regulatory-review-period-for-purposes-of-patent-extension-esbriet2026-10-17T06:34:34.737Z0.6https://business-news.org/article/419817-determination-of-regulatory-review-period-for-purposes-of-patent-extension-lymphoseek2026-10-17T06:34:34.808Z0.6https://business-news.org/article/419818-agency-information-collection-activities-proposed-collection-comment-request-new-animal-dr2026-10-17T06:34:34.700Z0.6https://business-news.org/article/419819-agency-information-collection-activities-proposed-collection-comment-request-medical-devic2026-10-17T06:34:35.681Z0.6https://business-news.org/article/419820-parke-davis-subsidiary-of-pfizer-inc-et-al-withdraw-of-approval-of-38-new-drug-application2026-10-17T06:34:35.260Z0.6https://business-news.org/article/419821-determination-of-regulatory-review-period-for-purposes-of-patent-extension-ofev2026-10-17T06:34:34.205Z0.6https://business-news.org/article/419822-agency-information-collection-activities-proposed-collection-comment-request-medical-devic2026-10-17T06:34:34.425Z0.6https://business-news.org/article/419823-agency-information-collection-activities-proposed-collection-comment-request-administrativ2026-10-17T06:34:34.511Z0.6https://business-news.org/article/419824-peripheral-and-central-nervous-system-drugs-advisory-committee-notice-of-meeting-establish2026-10-17T06:34:34.289Z0.6https://business-news.org/article/419825-human-subject-protection-acceptance-of-data-from-clinical-investigations-for-medical-devic2026-10-17T06:34:40.245Z0.6https://business-news.org/article/419826-statement-of-organization-functions-and-delegations-of-authority2026-10-17T06:34:45.713Z0.6https://business-news.org/article/419827-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T06:34:44.657Z0.6https://business-news.org/article/419828-determination-of-regulatory-review-period-for-purposes-of-patent-extension-portrazza2026-10-17T06:34:44.481Z0.6https://business-news.org/article/419829-determination-of-regulatory-review-period-for-purposes-of-patent-extension-maestro-recharg2026-10-17T06:34:44.415Z0.6https://business-news.org/article/419830-determination-of-regulatory-review-period-for-purposes-of-patent-extension-darzalex2026-10-17T06:34:44.228Z0.6https://business-news.org/article/419831-nicotine-steering-committee-establishment-of-a-public-docket-request-for-comments2026-10-17T06:34:44.477Z0.6https://business-news.org/article/419832-agency-information-collection-activities-proposed-collection-comment-request-animal-food-l2026-10-17T06:34:44.437Z0.6https://business-news.org/article/419833-determination-of-regulatory-review-period-for-purposes-of-patent-extension-movantik2026-10-17T06:34:50.849Z0.6https://business-news.org/article/419834-submission-of-content-necessary-for-bioresearch-monitoring-inspection-planning-for-the-cen2026-10-17T06:34:50.776Z0.6https://business-news.org/article/419835-pediatric-advisory-committee-establishment-of-a-public-docket-request-for-comments-amendme2026-10-17T06:34:50.826Z0.6https://business-news.org/article/419836-how-to-prepare-a-pre-request-for-designation-guidance-for-industry-availability2026-10-17T06:34:50.472Z0.6https://business-news.org/article/419837-determination-of-regulatory-review-period-for-purposes-of-patent-extension-hymovis2026-10-17T06:34:50.457Z0.6https://business-news.org/article/419838-early-alzheimer-s-disease-developing-drugs-for-treatment-draft-guidance-for-industry-avail2026-10-17T06:34:50.321Z0.6https://business-news.org/article/419839-duchenne-muscular-dystrophy-and-related-dystrophinopathies-developing-drugs-for-treatment-2026-10-17T06:34:50.410Z0.6https://business-news.org/article/419840-migraine-developing-drugs-for-acute-treatment-guidance-for-industry-availability2026-10-17T06:34:49.859Z0.6https://business-news.org/article/419841-drugs-for-treatment-of-partial-onset-seizures-full-extrapolation-of-efficacy-from-adults-t2026-10-17T06:34:49.987Z0.6https://business-news.org/article/419842-amyotrophic-lateral-sclerosis-developing-drugs-for-treatment-draft-guidance-for-industry-a2026-10-17T06:34:49.934Z0.6https://business-news.org/article/419843-determination-of-regulatory-review-period-for-purposes-of-patent-extension-cotellic2026-10-17T06:34:49.988Z0.6https://business-news.org/article/419844-pediatric-medical-device-development-public-meeting-request-for-comments2026-10-17T06:34:48.683Z0.6https://business-news.org/article/419845-determination-that-lotensin-hct-benazepril-hydrochloride-hydrochlorothiazide-oral-tablets-2026-10-17T06:34:48.694Z0.6https://business-news.org/article/419846-determination-of-regulatory-review-period-for-purposes-of-patent-extension-zontivity2026-10-17T06:34:58.767Z0.6https://business-news.org/article/419847-determination-of-regulatory-review-period-for-purposes-of-patent-extension-bridion2026-10-17T06:34:56.281Z0.6https://business-news.org/article/419848-determination-of-regulatory-review-period-for-purposes-of-patent-extension-aveed2026-10-17T06:34:56.071Z0.6https://business-news.org/article/419849-medical-devices-general-and-plastic-surgery-devices-classification-of-the-non-absorbable-h2026-10-17T06:34:56.282Z0.6https://business-news.org/article/419850-determination-of-regulatory-review-period-for-purposes-of-patent-extension-zydelig-new-dru2026-10-17T06:34:56.244Z0.6https://business-news.org/article/419851-regulatory-classification-of-pharmaceutical-co-crystals-guidance-for-industry-availability2026-10-17T06:34:54.777Z0.6https://business-news.org/article/419852-determination-of-regulatory-review-period-for-purposes-of-patent-extension-addyi2026-10-17T06:34:54.851Z0.6https://business-news.org/article/419853-determination-of-regulatory-review-period-for-purposes-of-patent-extension-fetzima2026-10-17T06:34:54.793Z0.6https://business-news.org/article/419854-determination-of-regulatory-review-period-for-purposes-of-patent-extension-orkambi2026-10-17T06:34:54.975Z0.6https://business-news.org/article/419855-determination-of-regulatory-review-period-for-purposes-of-patent-extension-sylvant2026-10-17T06:34:54.680Z0.6https://business-news.org/article/419856-determination-of-regulatory-review-period-for-purposes-of-patent-extension-beleodaq2026-10-17T06:35:02.997Z0.6https://business-news.org/article/419857-determination-of-regulatory-review-period-for-purposes-of-patent-extension-ibrance2026-10-17T06:35:01.806Z0.6https://business-news.org/article/419858-determination-of-regulatory-review-period-for-purposes-of-patent-extension-juvederm-voluma2026-10-17T06:35:01.849Z0.6https://business-news.org/article/419859-determination-of-regulatory-review-period-for-purposes-of-patent-extension-kerydin2026-10-17T06:35:02.091Z0.6https://business-news.org/article/419860-determination-of-regulatory-review-period-for-purposes-of-patent-extension-jardiance2026-10-17T06:35:01.882Z0.6https://business-news.org/article/419861-determination-of-regulatory-review-period-for-purposes-of-patent-extension-osurnia2026-10-17T06:35:01.768Z0.6https://business-news.org/article/419862-utilizing-innovative-statistical-methods-and-trial-designs-in-rare-disease-settings-public2026-10-17T06:35:02.014Z0.6https://business-news.org/article/419863-postmarketing-safety-reports-for-approved-new-animal-drugs-electronic-submission-requireme2026-10-17T06:35:02.271Z0.6https://business-news.org/article/419864-hospira-inc-et-al-withdrawal-of-approval-of-44-new-drug-applications-and-158-abbreviated-n2026-10-17T06:35:07.261Z0.6https://business-news.org/article/419865-mallinkrodt-pharmaceuticals-llc-withdrawal-of-approval-of-an-abbreviated-new-drug-applicat2026-10-17T06:35:05.434Z0.6https://business-news.org/article/419866-orthopaedic-sensing-measuring-and-advanced-reporting-technology-devices-public-workshop-re2026-10-17T06:35:05.595Z0.6https://business-news.org/article/419867-request-for-nominations-on-the-national-mammography-quality-assurance-advisory-committee2026-10-17T06:35:05.515Z0.6https://business-news.org/article/419868-proposal-to-refuse-to-approve-a-new-drug-application-for-oxycodone-hydrochloride-immediate2026-10-17T06:35:05.463Z0.6https://business-news.org/article/419869-bacillus-calmette-guerin-unresponsive-nonmuscle-invasive-bladder-cancer-developing-drugs-a2026-10-17T06:35:06.360Z0.6https://business-news.org/article/419870-determination-of-regulatory-review-period-for-purposes-of-patent-extension-farydak2026-10-17T06:35:06.306Z0.6https://business-news.org/article/419871-agency-information-collection-activities-proposed-collection-comment-request-generic-clear2026-10-17T06:35:04.938Z0.6https://business-news.org/article/419872-determination-of-regulatory-review-period-for-purposes-of-patent-extension-vascepa2026-10-17T06:35:05.026Z0.6https://business-news.org/article/419873-neurological-devices-panel-of-the-medical-devices-advisory-committee-amendment-of-notice2026-10-17T06:35:04.546Z0.6https://business-news.org/article/419874-packaging-storage-and-disposal-options-to-enhance-opioid-safety-exploring-the-path-forward2026-10-17T06:35:12.107Z0.6https://business-news.org/article/419875-determination-of-regulatory-review-period-for-purposes-of-patent-extension-imbruvica2026-10-17T06:35:11.976Z0.6https://business-news.org/article/419876-determination-of-regulatory-review-period-for-purposes-of-patent-extension-dalvance2026-10-17T06:35:11.487Z0.6https://business-news.org/article/419877-determination-of-regulatory-review-period-for-purposes-of-patent-extension-gilotrif2026-10-17T06:35:11.090Z0.6https://business-news.org/article/419878-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T06:35:10.868Z0.6https://business-news.org/article/419879-determination-of-regulatory-review-period-for-purposes-of-patent-extension-belsomra2026-10-17T06:35:10.983Z0.6https://business-news.org/article/419880-determination-of-regulatory-review-period-for-purposes-of-patent-extension-bravecto2026-10-17T06:35:10.758Z0.6https://business-news.org/article/419881-determination-of-regulatory-review-period-for-purposes-of-patent-extension-akynzeo2026-10-17T06:35:09.539Z0.6https://business-news.org/article/419882-determination-of-regulatory-review-period-for-purposes-of-patent-extension-idelvion2026-10-17T06:35:13.474Z0.6https://business-news.org/article/419883-determination-of-regulatory-review-period-for-purposes-of-patent-extension-odomzo2026-10-17T06:35:13.073Z0.6https://business-news.org/article/419884-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T06:35:13.260Z0.6https://business-news.org/article/419885-determination-of-regulatory-review-period-for-purposes-of-patent-extension-entresto2026-10-17T06:35:12.803Z0.6https://business-news.org/article/419886-determination-of-regulatory-review-period-for-purposes-of-patent-extension-lynparza2026-10-17T06:35:12.842Z0.6https://business-news.org/article/419887-determination-of-regulatory-review-period-for-purposes-of-patent-extension-onivyde2026-10-17T06:35:13.257Z0.6https://business-news.org/article/419888-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T06:35:13.453Z0.6https://business-news.org/article/419889-determination-of-regulatory-review-period-for-purposes-of-patent-extension-strensiq2026-10-17T06:35:12.359Z0.6https://business-news.org/article/419890-determination-of-regulatory-review-period-for-purposes-of-patent-extension-kamra-inlay2026-10-17T06:35:12.785Z0.6https://business-news.org/article/419891-determination-of-regulatory-review-period-for-purposes-of-patent-extension-jublia2026-10-17T06:35:15.976Z0.6https://business-news.org/article/419892-determination-of-regulatory-review-period-for-purposes-of-patent-extension-sedasys-system2026-10-17T06:35:21.328Z0.6https://business-news.org/article/419893-determination-of-regulatory-review-period-for-purposes-of-patent-extension-blincyto2026-10-17T06:35:21.346Z0.6https://business-news.org/article/419894-determination-of-regulatory-review-period-for-purposes-of-patent-extension-farxiga2026-10-17T06:35:21.190Z0.6https://business-news.org/article/419895-agency-information-collection-activities-proposed-collection-comment-request-state-enforce2026-10-17T06:35:20.869Z0.6https://business-news.org/article/419896-agency-information-collection-activities-proposed-collection-comment-request-survey-on-the2026-10-17T06:35:20.617Z0.6https://business-news.org/article/419897-agency-information-collection-activities-proposed-collection-comment-request-survey-on-the2026-10-17T06:35:20.617Z0.6https://business-news.org/article/419898-determination-of-regulatory-review-period-for-purposes-of-patent-extension-genvoya2026-10-17T06:35:20.143Z0.6https://business-news.org/article/419899-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T06:35:30.450Z0.6https://business-news.org/article/419900-medical-devices-neurological-devices-classification-of-the-percutaneous-nerve-stimulator-f2026-10-17T06:35:30.113Z0.6https://business-news.org/article/419901-determination-of-regulatory-review-period-for-purposes-of-patent-extension-viberzi2026-10-17T06:35:28.894Z0.6https://business-news.org/article/419902-hazard-analysis-and-risk-based-preventive-controls-for-food-for-animals-draft-guidance-for2026-10-17T06:35:28.860Z0.6https://business-news.org/article/419903-best-practices-in-modeling-and-simulation-for-oncology-products-public-workshop2026-10-17T06:35:34.452Z0.6https://business-news.org/article/419904-determination-of-regulatory-review-period-for-purposes-of-patent-extension-corlanor2026-10-17T06:35:34.411Z0.6https://business-news.org/article/419905-determination-of-regulatory-review-period-for-purposes-of-patent-extension-lenvima2026-10-17T06:35:41.175Z0.6https://business-news.org/article/419906-listing-of-color-additives-exempt-from-certification-calcium-carbonate-confirmation-of-eff2026-10-17T06:35:41.045Z0.6https://business-news.org/article/419907-determination-of-regulatory-review-period-for-purposes-of-patent-extension-duavee2026-10-17T06:35:40.874Z0.6https://business-news.org/article/419908-determination-of-regulatory-review-period-for-purposes-of-patent-extension-cresemba-new-dr2026-10-17T06:35:40.794Z0.6https://business-news.org/article/419909-determination-of-regulatory-review-period-for-purposes-of-patent-extension-sapien-xt-trans2026-10-17T06:35:40.763Z0.6https://business-news.org/article/419910-determination-of-regulatory-review-period-for-purposes-of-patent-extension-keytruda2026-10-17T06:35:40.592Z0.6https://business-news.org/article/419911-determination-of-regulatory-review-period-for-purposes-of-patent-extension-mobi-c-cervical2026-10-17T06:35:40.453Z0.6https://business-news.org/article/419912-qualified-infectious-disease-product-designation-questions-and-answers-draft-guidance-for-2026-10-17T06:35:44.967Z0.6https://business-news.org/article/419913-determination-of-regulatory-review-period-for-purposes-of-patent-extension-sapien-3-transc2026-10-17T06:35:44.826Z0.6https://business-news.org/article/419914-determination-of-regulatory-review-period-for-purposes-of-patent-extension-viekira-pak2026-10-17T06:35:45.075Z0.6https://business-news.org/article/419915-determination-of-regulatory-review-period-for-purposes-of-patent-extension-cresemba-new-dr2026-10-17T06:35:44.985Z0.6https://business-news.org/article/419916-determination-of-regulatory-review-period-for-purposes-of-patent-extension-cardiomems-hf-m2026-10-17T06:35:45.059Z0.6https://business-news.org/article/419917-evaluating-inclusion-and-exclusion-criteria-in-clinical-trials-public-meeting2026-10-17T06:35:45.016Z0.6https://business-news.org/article/419918-determination-of-regulatory-review-period-for-purposes-of-patent-extension-zepatier2026-10-17T06:35:44.322Z0.6https://business-news.org/article/419919-determination-of-regulatory-review-period-for-purposes-of-patent-extension-lonsurf2026-10-17T06:35:44.534Z0.6https://business-news.org/article/419920-determination-of-regulatory-review-period-for-purposes-of-patent-extension-galliprant2026-10-17T06:35:44.475Z0.6https://business-news.org/article/419921-medical-devices-general-and-plastic-surgery-devices-classification-of-the-surgical-smoke-p2026-10-17T06:35:44.375Z0.6https://business-news.org/article/419922-medical-devices-cardiovascular-devices-classification-of-the-temporary-catheter-for-emboli2026-10-17T06:35:44.683Z0.6https://business-news.org/article/419923-determination-of-regulatory-review-period-for-purposes-of-patent-extension-uptravi2026-10-17T06:35:44.655Z0.6https://business-news.org/article/419924-international-drug-scheduling-convention-on-psychotropic-substances-single-convention-on-n2026-10-17T06:35:56.318Z0.6https://business-news.org/article/419925-agency-information-collection-activities-proposed-collection-comment-request-irradiation-i2026-10-17T06:35:56.393Z0.6https://business-news.org/article/419926-removal-of-certain-time-of-inspection-and-duties-of-inspector-regulations-for-biological-p2026-10-17T06:35:55.202Z0.6https://business-news.org/article/419927-removal-of-certain-time-of-inspection-and-duties-of-inspector-regulations-for-biological-p2026-10-17T06:35:54.736Z0.6https://business-news.org/article/419928-advisory-committee-pharmaceutical-science-and-clinical-pharmacology-advisory-committee-ren2026-10-17T06:35:54.975Z0.6https://business-news.org/article/419929-determination-of-regulatory-review-period-for-purposes-of-patent-extension-varubi2026-10-17T06:35:54.756Z0.6https://business-news.org/article/419930-determination-of-regulatory-review-period-for-purposes-of-patent-extension-vraylar2026-10-17T06:35:55.293Z0.6https://business-news.org/article/419931-hypertension-developing-fixed-dose-combination-drugs-for-treatment-draft-guidance-for-indu2026-10-17T06:35:54.988Z0.6https://business-news.org/article/419932-recommendations-for-dual-510-k-and-clinical-laboratory-improvement-amendments-waiver-by-ap2026-10-17T06:35:54.609Z0.6https://business-news.org/article/419933-select-updates-for-recommendations-for-clinical-laboratory-improvement-amendments-of-1988-2026-10-17T06:35:54.405Z0.6https://business-news.org/article/419934-foreign-supplier-verification-programs-for-importers-of-food-for-humans-and-animals-what-y2026-10-17T06:36:01.276Z0.6https://business-news.org/article/419935-hazard-analysis-and-risk-based-preventive-controls-for-human-food-draft-guidance-for-indus2026-10-17T06:36:01.304Z0.6https://business-news.org/article/419936-application-of-the-foreign-supplier-verification-program-regulation-to-importers-of-grain-2026-10-17T06:36:00.890Z0.6https://business-news.org/article/419937-foreign-supplier-verification-programs-for-importers-of-food-for-humans-and-animals-draft-2026-10-17T06:36:00.848Z0.6https://business-news.org/article/419938-considerations-for-determining-whether-a-measure-provides-the-same-level-of-public-health-2026-10-17T06:36:00.832Z0.6https://business-news.org/article/419939-hazard-analysis-and-risk-based-preventive-controls-for-food-for-animals-draft-guidance-for2026-10-17T06:36:10.319Z0.6https://business-news.org/article/419940-agency-information-collection-activities-proposed-collection-comment-request-current-good-2026-10-17T06:36:10.081Z0.6https://business-news.org/article/419941-the-least-burdensome-provisions-concept-and-principles-draft-guidance-for-industry-and-foo2026-10-17T06:36:09.984Z0.6https://business-news.org/article/419942-agency-information-collection-activities-proposed-collection-comment-request-draft-guidanc2026-10-17T06:36:08.673Z0.6https://business-news.org/article/419943-electronic-study-data-submission-data-standards-timetable-for-updates-to-the-food-and-drug2026-10-17T06:36:09.003Z0.6https://business-news.org/article/419944-watson-laboratories-inc-withdrawal-of-approval-of-abbreviated-new-drug-applications-for-pr2026-10-17T06:36:08.903Z0.6https://business-news.org/article/419945-determination-of-regulatory-review-period-for-purposes-of-patent-extension-perceval-suture2026-10-17T06:36:12.297Z0.6https://business-news.org/article/419946-determination-of-regulatory-review-period-for-purposes-of-patent-extension-ninlaro2026-10-17T06:36:12.229Z0.6https://business-news.org/article/419947-determination-of-regulatory-review-period-for-purposes-of-patent-extension-zurampic2026-10-17T06:36:11.828Z0.6https://business-news.org/article/419948-devices-proposed-for-a-new-use-with-an-approved-marketed-drug-public-hearing-reopening-of-2026-10-17T06:36:12.132Z0.6https://business-news.org/article/419949-public-warning-and-notification-of-recalls-under-21-cfr-part-7-subpart-c-draft-guidance-fo2026-10-17T06:36:16.221Z0.6https://business-news.org/article/419950-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T06:36:14.698Z0.6https://business-news.org/article/419951-mixing-diluting-or-repackaging-biological-products-outside-the-scope-of-an-approved-biolog2026-10-17T06:36:14.905Z0.6https://business-news.org/article/419952-compounded-drug-products-that-are-essentially-copies-of-a-commercially-available-drug-prod2026-10-17T06:36:14.624Z0.6https://business-news.org/article/419953-compounded-drug-products-that-are-essentially-copies-of-approved-drug-products-under-secti2026-10-17T06:36:14.796Z0.6https://business-news.org/article/419954-material-threat-medical-countermeasure-priority-review-vouchers-draft-guidance-for-industr2026-10-17T06:36:14.580Z0.6https://business-news.org/article/419955-product-title-and-initial-u-s-approval-in-highlights-for-human-prescription-drug-and-biolo2026-10-17T06:36:14.514Z0.6https://business-news.org/article/419956-laser-products-conformance-with-iec-60825-1-ed-3-and-iec-60601-2-22-ed-3-1-laser-notice-no2026-10-17T06:36:14.132Z0.6https://business-news.org/article/419957-william-ralph-kincaid-denial-of-hearing-final-debarment-order2026-10-17T06:36:22.693Z0.6https://business-news.org/article/419958-delcor-asset-corp-et-al-withdrawal-of-approval-of-22-abbreviated-new-drug-applications2026-10-17T06:36:25.026Z0.6https://business-news.org/article/419959-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T06:36:25.865Z0.6https://business-news.org/article/419960-determination-of-regulatory-review-period-for-purposes-of-patent-extension-axumin2026-10-17T06:36:25.721Z0.6https://business-news.org/article/419961-food-labeling-health-claims-soy-protein-and-coronary-heart-disease-extension-of-comment-pe2026-10-17T06:36:25.419Z0.6https://business-news.org/article/419962-determination-of-regulatory-review-period-for-purposes-of-patent-extension-synergy-everoli2026-10-17T06:36:24.894Z0.6https://business-news.org/article/419963-determination-of-regulatory-review-period-for-purposes-of-patent-extension-avycaz2026-10-17T06:36:24.739Z0.6https://business-news.org/article/419964-agency-information-collection-activities-proposed-collection-comment-request-veterinary-fe2026-10-17T06:36:24.681Z0.6https://business-news.org/article/419965-determination-of-regulatory-review-period-for-purposes-of-patent-extension-daklinza2026-10-17T06:36:24.645Z0.6https://business-news.org/article/419966-internal-agency-review-of-decisions-requests-for-supervisory-review-of-certain-decisions-m2026-10-17T06:36:25.266Z0.6https://business-news.org/article/419967-clarification-of-when-products-made-or-derived-from-tobacco-are-regulated-as-drugs-devices2026-10-17T06:36:32.404Z0.6https://business-news.org/article/419968-accreditation-scheme-for-conformity-assessment-of-medical-devices-to-food-and-drug-adminis2026-10-17T06:36:31.864Z0.6https://business-news.org/article/419969-unique-device-identification-policy-regarding-compliance-dates-for-class-i-and-unclassifie2026-10-17T06:36:31.842Z0.6https://business-news.org/article/419970-clarification-of-orphan-designation-of-drugs-and-biologics-for-pediatric-subpopulations-of2026-10-17T06:36:33.900Z0.6https://business-news.org/article/419971-determining-whether-to-submit-an-abbreviated-new-drug-application-or-505-b-2-application-d2026-10-17T06:36:33.798Z0.6https://business-news.org/article/419972-determination-of-regulatory-review-period-for-purposes-of-patent-extension-proact-adjustab2026-10-17T06:36:33.867Z0.6https://business-news.org/article/419973-determination-of-regulatory-review-period-for-purposes-of-patent-extension-entyce2026-10-17T06:36:40.271Z0.6https://business-news.org/article/419974-risk-communication-advisory-committee-notice-of-meeting-establishment-of-a-public-docket-r2026-10-17T06:36:40.470Z0.6https://business-news.org/article/419975-determination-of-regulatory-review-period-for-purposes-of-patent-extension-micra-transcath2026-10-17T06:36:40.314Z0.6https://business-news.org/article/419976-determination-of-regulatory-review-period-for-purposes-of-patent-extension-epanova2026-10-17T06:36:40.181Z0.6https://business-news.org/article/419977-advisory-committee-vaccines-and-related-biological-products-advisory-committee-renewal2026-10-17T06:36:42.582Z0.6https://business-news.org/article/419978-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T06:36:42.557Z0.6https://business-news.org/article/419979-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T06:36:42.407Z0.6https://business-news.org/article/419980-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T06:36:46.147Z0.6https://business-news.org/article/419981-medical-devices-radiology-devices-classification-of-the-absorbable-perirectal-spacer2026-10-17T06:36:50.751Z0.6https://business-news.org/article/419982-policy-regarding-certain-entities-subject-to-the-current-good-manufacturing-practice-and-p2026-10-17T06:36:50.724Z0.6https://business-news.org/article/419983-good-abbreviated-new-drug-application-submission-practices-draft-guidance-for-industry-ava2026-10-17T06:36:51.262Z0.6https://business-news.org/article/419984-medical-devices-hematology-and-pathology-devices-classification-of-a-cervical-intraepithel2026-10-17T06:36:52.911Z0.6https://business-news.org/article/419985-establishing-effectiveness-for-drugs-intended-to-treat-male-hypogonadotropic-hypogonadism-2026-10-17T06:36:52.413Z0.6https://business-news.org/article/419986-medical-devices-hematology-and-pathology-devices-classification-of-the-whole-slide-imaging2026-10-17T06:36:56.250Z0.6https://business-news.org/article/419987-pediatric-advisory-committee-notice-of-meeting-establishment-of-a-public-docket-request-fo2026-10-17T06:36:56.341Z0.6https://business-news.org/article/419988-agency-information-collection-activities-proposed-collection-comment-request-food-and-cosm2026-10-17T06:36:56.185Z0.6https://business-news.org/article/419989-issuance-of-priority-review-voucher-rare-pediatric-disease-product2026-10-17T06:36:54.703Z0.6https://business-news.org/article/419990-medical-devices-general-and-plastic-surgery-devices-classification-of-the-irrigating-wound2026-10-17T06:36:54.779Z0.6https://business-news.org/article/419991-watson-laboratories-inc-subsidiary-of-teva-pharmaceuticals-usa-inc-et-al-withdrawal-of-app2026-10-17T06:36:54.839Z0.6https://business-news.org/article/419992-watson-laboratories-inc-and-barr-laboratories-inc-subsidiaries-of-teva-pharmaceuticals-usa2026-10-17T06:36:54.898Z0.6https://business-news.org/article/419993-labeling-for-combined-hormonal-contraceptives-draft-guidance-for-industry-availability2026-10-17T06:36:55.241Z0.6https://business-news.org/article/419994-food-additives-permitted-in-feed-and-drinking-water-of-animals-formic-acid-as-a-feed-acidi2026-10-17T06:36:54.780Z0.6https://business-news.org/article/419995-radio-broadcasting-services-gaylord-michigan2026-10-17T06:37:05.048Z0.6https://business-news.org/article/419996-elimination-of-main-studio-rule-correction2026-10-17T06:37:24.232Z0.6https://business-news.org/article/419997-accelerating-wireline-broadband-deployment-by-removing-barriers-to-infrastructure-investme2026-10-17T06:37:24.024Z0.6https://business-news.org/article/419998-accelerating-wireline-broadband-deployment-by-removing-barriers-to-infrastructure-investme2026-10-17T06:37:24.492Z0.6https://business-news.org/article/419999-closed-captioning-of-video-programming-telecommunications-for-the-deaf-and-hard-of-hearing2026-10-17T06:38:21.238Z0.6https://business-news.org/article/420000-fourth-meeting-of-the-broadband-deployment-advisory-committee2026-10-17T06:38:34.495Z0.6